Zeke Capital Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 207.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,208 shares of the medical equipment provider’s stock after acquiring an additional 1,491 shares during the quarter. Zeke Capital Advisors LLC’s holdings in Intuitive Surgical were worth $806,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. MUFG Americas Holdings Corp acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $208,000. Coldstream Capital Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $214,000. Synovus Financial Corp acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $242,000. Park Avenue Securities LLC acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $300,000. Finally, CWM LLC increased its position in Intuitive Surgical by 200.0% in the 4th quarter. CWM LLC now owns 285 shares of the medical equipment provider’s stock valued at $104,000 after acquiring an additional 190 shares during the period. Hedge funds and other institutional investors own 87.85% of the company’s stock.
Several brokerages have issued reports on ISRG. Barclays restated an “overweight” rating and issued a $465.00 price target on shares of Intuitive Surgical in a research report on Thursday, January 11th. Piper Jaffray Companies reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Friday, January 26th. ValuEngine cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. BidaskClub upgraded shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 11th. Finally, Vetr cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $447.93 price objective for the company. in a research report on Tuesday, February 27th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $408.76.
In related news, Director Lonnie M. Smith sold 18,000 shares of the stock in a transaction on Tuesday, January 30th. The shares were sold at an average price of $428.68, for a total transaction of $7,716,240.00. Following the transaction, the director now directly owns 511,410 shares of the company’s stock, valued at $219,231,238.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Marshall Mohr sold 7,500 shares of the stock in a transaction on Monday, February 5th. The stock was sold at an average price of $414.19, for a total transaction of $3,106,425.00. Following the transaction, the chief financial officer now directly owns 13,816 shares in the company, valued at $5,722,449.04. The disclosure for this sale can be found here. Over the last three months, insiders have sold 102,770 shares of company stock worth $43,410,836. 2.20% of the stock is owned by insiders.
Intuitive Surgical, Inc. (ISRG) opened at $435.86 on Friday. The stock has a market cap of $49,967.79, a price-to-earnings ratio of 76.74, a P/E/G ratio of 5.26 and a beta of 0.51. Intuitive Surgical, Inc. has a 12 month low of $247.50 and a 12 month high of $452.00.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.27. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. Intuitive Surgical’s revenue was up 17.9% on a year-over-year basis. During the same period in the prior year, the firm earned $2.03 earnings per share. equities analysts anticipate that Intuitive Surgical, Inc. will post 7.85 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/03/17/zeke-capital-advisors-llc-acquires-1491-shares-of-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.